Technical Analysis for 0IV3 - Geron Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Fell Below 20 DMA | Bearish | 10.52% | |
| Down 3 Days in a Row | Weakness | 10.52% | |
| Gapped Down | Weakness | 10.52% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 5.79% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 5.79% | |
| Inside Day | Range Contraction | 5.79% | |
| Outside Day | Range Expansion | 5.50% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 22 hours ago |
| Possible NR7 | about 22 hours ago |
| Up 3% | about 22 hours ago |
| Rose Above 20 DMA | about 22 hours ago |
| Up 2% | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Keywords: Branches Of Biology Biology Stem Cells High Risk Myelofibrosis Myelodysplastic Syndrome Myelofibrosis
Classification
Keywords: Branches Of Biology Biology Stem Cells High Risk Myelofibrosis Myelodysplastic Syndrome Myelofibrosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.005 |
| 52 Week Low | 1.731 |
| Average Volume | 25,213 |
| 200-Day Moving Average | 2.55 |
| 50-Day Moving Average | 2.86 |
| 20-Day Moving Average | 3.51 |
| 10-Day Moving Average | 3.64 |
| Average True Range | 0.19 |
| RSI (14) | 62.26 |
| ADX | 41.85 |
| +DI | 38.38 |
| -DI | 21.08 |
| Chandelier Exit (Long, 3 ATRs) | 3.42 |
| Chandelier Exit (Short, 3 ATRs) | 3.68 |
| Upper Bollinger Bands | 3.92 |
| Lower Bollinger Band | 3.10 |
| Percent B (%b) | 0.84 |
| BandWidth | 23.20 |
| MACD Line | 0.21 |
| MACD Signal Line | 0.25 |
| MACD Histogram | -0.0382 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.16 | ||||
| Resistance 3 (R3) | 4.13 | 3.97 | 4.10 | ||
| Resistance 2 (R2) | 3.97 | 3.88 | 3.99 | 4.08 | |
| Resistance 1 (R1) | 3.88 | 3.82 | 3.93 | 3.91 | 4.06 |
| Pivot Point | 3.72 | 3.72 | 3.74 | 3.73 | 3.72 |
| Support 1 (S1) | 3.62 | 3.62 | 3.67 | 3.65 | 3.51 |
| Support 2 (S2) | 3.46 | 3.56 | 3.48 | 3.48 | |
| Support 3 (S3) | 3.37 | 3.46 | 3.46 | ||
| Support 4 (S4) | 3.40 |
